skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 1,542  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Refined by: subject: Aged remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout
Material Type:
Article
Add to My Research

Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout

The New England journal of medicine, 2018-03, Vol.378 (13), p.1200-1210 [Peer Reviewed Journal]

Copyright © 2018 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1710895 ;PMID: 29527974

Full text available

2
Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors
Material Type:
Article
Add to My Research

Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors

Nature reviews. Rheumatology, 2020-07, Vol.16 (7), p.380-390 [Peer Reviewed Journal]

COPYRIGHT 2020 Nature Publishing Group ;Springer Nature Limited 2020. ;ISSN: 1759-4790 ;EISSN: 1759-4804 ;DOI: 10.1038/s41584-020-0441-1 ;PMID: 32541923

Full text available

3
Predictors of disease activity in gout: a 12-month analysis of the ATTACk (Achieving improvement in the management of crystal-induced arthritis) multicentre cohort study
Material Type:
Article
Add to My Research

Predictors of disease activity in gout: a 12-month analysis of the ATTACk (Achieving improvement in the management of crystal-induced arthritis) multicentre cohort study

Clinical and experimental rheumatology, 2023-03, Vol.41 (3), p.628-633 [Peer Reviewed Journal]

ISSN: 0392-856X ;ISSN: 1593-098X ;EISSN: 1593-098X ;DOI: 10.55563/clinexprheumatol/eh0jcp ;PMID: 35930471

Full text available

4
Lesinurad in combination with allopurinol: a randomised, double-blind, placebo-controlled study in patients with gout with inadequate response to standard of care (the multinational CLEAR 2 study)
Material Type:
Article
Add to My Research

Lesinurad in combination with allopurinol: a randomised, double-blind, placebo-controlled study in patients with gout with inadequate response to standard of care (the multinational CLEAR 2 study)

Annals of the rheumatic diseases, 2017-05, Vol.76 (5), p.811-820 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/. ;Copyright: 2016 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ 2016 ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2016-209213 ;PMID: 27821644 ;CODEN: ARDIAO

Full text available

5
Long-term cardiovascular safety of febuxostat compared with allopurinol in patients with gout (FAST): a multicentre, prospective, randomised, open-label, non-inferiority trial
Material Type:
Article
Add to My Research

Long-term cardiovascular safety of febuxostat compared with allopurinol in patients with gout (FAST): a multicentre, prospective, randomised, open-label, non-inferiority trial

The Lancet (British edition), 2020-11, Vol.396 (10264), p.1745-1757 [Peer Reviewed Journal]

2020 Elsevier Ltd ;Copyright © 2020 Elsevier Ltd. All rights reserved. ;2020. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)32234-0 ;PMID: 33181081

Full text available

6
Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000–2005
Material Type:
Article
Add to My Research

Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000–2005

Annals of the rheumatic diseases, 2008-07, Vol.67 (7), p.960-966 [Peer Reviewed Journal]

2008 BMJ Publishing Group and European League Against Rheumatism ;2008 INIST-CNRS ;Copyright: 2008 2008 BMJ Publishing Group and European League Against Rheumatism ;Annemans et al 2008 2008 ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/ard.2007.076232 ;PMID: 17981913 ;CODEN: ARDIAO

Full text available

7
National prevalence of gout derived from administrative health data in Aotearoa New Zealand
Material Type:
Article
Add to My Research

National prevalence of gout derived from administrative health data in Aotearoa New Zealand

Rheumatology (Oxford, England), 2012-05, Vol.51 (5), p.901-909 [Peer Reviewed Journal]

2015 INIST-CNRS ;ISSN: 1462-0324 ;EISSN: 1462-0332 ;DOI: 10.1093/rheumatology/ker361 ;PMID: 22253023

Full text available

8
Pharmacodynamic, pharmacokinetic and tolerability evaluation of concomitant administration of lesinurad and febuxostat in gout patients with hyperuricaemia
Material Type:
Article
Add to My Research

Pharmacodynamic, pharmacokinetic and tolerability evaluation of concomitant administration of lesinurad and febuxostat in gout patients with hyperuricaemia

Rheumatology (Oxford, England), 2014-12, Vol.53 (12), p.2167-2174 [Peer Reviewed Journal]

The Author 2014. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oup.com. ;ISSN: 1462-0324 ;EISSN: 1462-0332 ;DOI: 10.1093/rheumatology/ket487 ;PMID: 24509406

Full text available

9
ABCG2 loss-of-function polymorphism predicts poor response to allopurinol in patients with gout
Material Type:
Article
Add to My Research

ABCG2 loss-of-function polymorphism predicts poor response to allopurinol in patients with gout

The pharmacogenomics journal, 2017-03, Vol.17 (2), p.201-203 [Peer Reviewed Journal]

Copyright Nature Publishing Group Mar 2017 ;Macmillan Publishers Limited, part of Springer Nature. 2017. ;ISSN: 1470-269X ;EISSN: 1473-1150 ;DOI: 10.1038/tpj.2015.101 ;PMID: 26810134

Full text available

10
Ultrasound shows rapid reduction of crystal depositions during a treat-to-target approach in gout patients: 12-month results from the NOR-Gout study
Material Type:
Article
Add to My Research

Ultrasound shows rapid reduction of crystal depositions during a treat-to-target approach in gout patients: 12-month results from the NOR-Gout study

Annals of the rheumatic diseases, 2020-11, Vol.79 (11), p.1500-1505 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;2020 Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2020-217392 ;PMID: 32669301

Full text available

11
Comorbidity in gout at the time of first diagnosis: sex differences that may have implications for dosing of urate lowering therapy
Material Type:
Article
Add to My Research

Comorbidity in gout at the time of first diagnosis: sex differences that may have implications for dosing of urate lowering therapy

Arthritis research & therapy, 2018-06, Vol.20 (1), p.108-108, Article 108 [Peer Reviewed Journal]

COPYRIGHT 2018 BioMed Central Ltd. ;Copyright © 2018. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2018 ;ISSN: 1478-6362 ;ISSN: 1478-6354 ;EISSN: 1478-6362 ;DOI: 10.1186/s13075-018-1596-x ;PMID: 29855389

Full text available

12
Gout, flares, and allopurinol use: a population-based study
Material Type:
Article
Add to My Research

Gout, flares, and allopurinol use: a population-based study

Arthritis research & therapy, 2019-05, Vol.21 (1), p.132-8, Article 132 [Peer Reviewed Journal]

COPYRIGHT 2019 BioMed Central Ltd. ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 1478-6362 ;ISSN: 1478-6354 ;EISSN: 1478-6362 ;DOI: 10.1186/s13075-019-1918-7 ;PMID: 31151457

Full text available

13
Risk of chronic kidney disease in patients with gout and the impact of urate lowering therapy: a population-based cohort study
Material Type:
Article
Add to My Research

Risk of chronic kidney disease in patients with gout and the impact of urate lowering therapy: a population-based cohort study

Arthritis research & therapy, 2018-10, Vol.20 (1), p.243-10, Article 243 [Peer Reviewed Journal]

COPYRIGHT 2018 BioMed Central Ltd. ;Copyright © 2018. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2018 ;ISSN: 1478-6362 ;ISSN: 1478-6354 ;EISSN: 1478-6362 ;DOI: 10.1186/s13075-018-1746-1 ;PMID: 30376864

Full text available

14
Cardiovascular Risks of Probenecid Versus Allopurinol in Older Patients With Gout
Material Type:
Article
Add to My Research

Cardiovascular Risks of Probenecid Versus Allopurinol in Older Patients With Gout

Journal of the American College of Cardiology, 2018-03, Vol.71 (9), p.994-1004 [Peer Reviewed Journal]

2018 American College of Cardiology Foundation ;Copyright © 2018 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Mar 6, 2018 ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2017.12.052 ;PMID: 29496000

Full text available

15
Efficacy and safety of febuxostat extended release and immediate release in patients with gout and moderate renal impairment: phase II placebo-controlled study
Material Type:
Article
Add to My Research

Efficacy and safety of febuxostat extended release and immediate release in patients with gout and moderate renal impairment: phase II placebo-controlled study

Arthritis research & therapy, 2018-05, Vol.20 (1), p.99-99, Article 99 [Peer Reviewed Journal]

COPYRIGHT 2018 BioMed Central Ltd. ;Copyright © 2018. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2018 ;ISSN: 1478-6362 ;ISSN: 1478-6354 ;EISSN: 1478-6362 ;DOI: 10.1186/s13075-018-1593-0 ;PMID: 29848361

Full text available

16
The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial
Material Type:
Article
Add to My Research

The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial

Arthritis research & therapy, 2010-01, Vol.12 (2), p.R63-R63 [Peer Reviewed Journal]

COPYRIGHT 2010 BioMed Central Ltd. ;Copyright ©2010 Becker et al.; licensee BioMed Central Ltd. 2010 Becker et al.; licensee BioMed Central Ltd. ;ISSN: 1478-6354 ;EISSN: 1478-6362 ;DOI: 10.1186/ar2978 ;PMID: 20370912

Full text available

17
Venous thromboembolism in patients with gout and the impact of hospital admission, disease duration and urate-lowering therapy
Material Type:
Article
Add to My Research

Venous thromboembolism in patients with gout and the impact of hospital admission, disease duration and urate-lowering therapy

Canadian Medical Association journal (CMAJ), 2019-06, Vol.191 (22), p.E597-E603 [Peer Reviewed Journal]

2019 Joule Inc. or its licensors or its licensors ;2019 Joule Inc. or its licensors or its licensors. ;COPYRIGHT 2019 Joule Inc. ;Copyright Joule Inc Jun 3, 2019 ;2019 Joule Inc. or its licensors or its licensors 2019 ;ISSN: 0820-3946 ;EISSN: 1488-2329 ;DOI: 10.1503/cmaj.180717 ;PMID: 31160496

Full text available

18
Febuxostat in the treatment of gout: 5-yr findings of the FOCUS efficacy and safety study
Material Type:
Article
Add to My Research

Febuxostat in the treatment of gout: 5-yr findings of the FOCUS efficacy and safety study

Rheumatology (Oxford, England), 2009-02, Vol.48 (2), p.188-194 [Peer Reviewed Journal]

The Author 2009. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org 2009 ;2009 INIST-CNRS ;The Author 2009. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org ;ISSN: 1462-0324 ;EISSN: 1462-0332 ;DOI: 10.1093/rheumatology/ken457 ;PMID: 19141576 ;CODEN: BJRHDF

Full text available

19
Assessment of Cardiovascular Risk in Older Patients With Gout Initiating Febuxostat Versus Allopurinol: Population-Based Cohort Study
Material Type:
Article
Add to My Research

Assessment of Cardiovascular Risk in Older Patients With Gout Initiating Febuxostat Versus Allopurinol: Population-Based Cohort Study

Circulation (New York, N.Y.), 2018-09, Vol.138 (11), p.1116-1126 [Peer Reviewed Journal]

2018 by the American College of Cardiology Foundation and the American Heart Association, Inc. ;ISSN: 0009-7322 ;EISSN: 1524-4539 ;DOI: 10.1161/CIRCULATIONAHA.118.033992 ;PMID: 29899013

Full text available

20
A randomised controlled trial of the efficacy and safety of allopurinol dose escalation to achieve target serum urate in people with gout
Material Type:
Article
Add to My Research

A randomised controlled trial of the efficacy and safety of allopurinol dose escalation to achieve target serum urate in people with gout

Annals of the rheumatic diseases, 2017-09, Vol.76 (9), p.1522-1528 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/. ;Copyright: 2017 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2016-210872 ;PMID: 28314755

Full text available

Results 1 - 20 of 1,542  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (1,385)

Refine My Results

Creation Date 

From To
  1. Before 1973  (107)
  2. 1973 To 1985  (162)
  3. 1986 To 1998  (116)
  4. 1999 To 2012  (461)
  5. After 2012  (701)
  6. More options open sub menu

Resource Type 

  1. Articles  (1,538)
  2. magazinearticle  (3)
  3. Web Resources  (1)
  4. More options open sub menu

Language 

  1. English  (1,498)
  2. Japanese  (163)
  3. French  (15)
  4. German  (12)
  5. Spanish  (9)
  6. Russian  (6)
  7. Italian  (3)
  8. Chinese  (2)
  9. Polish  (1)
  10. Norwegian  (1)
  11. Serbian  (1)
  12. Turkish  (1)
  13. Afrikaans  (1)
  14. Icelandic  (1)
  15. More options open sub menu

Searching Remote Databases, Please Wait